Search Results - "Mazloom, Anisha"

Implementing Pediatric Surviving Sepsis Campaign Guidelines: Improving Compliance With Lactate Measurement in the PICU by Mazloom, Anisha, Sears, Stacey M, Carlton, Erin F, Bates, Katherine E, Flori, Heidi R

“…The 2020 pediatric Surviving Sepsis Campaign (pSSC) recommends measuring lactate during the first hour of resuscitation for severe sepsis/shock. We aimed to…”
Get full text

CTA095, a novel Etk and Src dual inhibitor, induces apoptosis in prostate cancer cells and overcomes resistance to Src inhibitors by Guo, Wenchang, Liu, Ruiwu, Bhardwaj, Gaurav, Ma, Ai-Hong, Changou, Chun, Yang, Joy C, Li, Yuanpei, Feng, Caihong, Luo, Yan, Mazloom, Anisha, Sanchez, Eduardo, Wang, Yan, Huang, Wenzhe, Patterson, Randen, Evans, Christopher P, Lam, Kit S, Kung, Hsing-Jien

“…Etk is a non-receptor tyrosine kinase, which provides a strong survival signal in human prostate cancer cells. Src, another tyrosine kinase that…”
Get full text

1262: IMPLEMENTING PEDIATRIC SURVIVING SEPSIS CAMPAIGN GUIDELINES: IMPROVING MEASUREMENT OF LACTATE by Mazloom, Anisha, Sears, Stacey, Carlton, Erin, Bates, Katherine, Flori, Heidi

Get full text

Using the Electronic Medical Record (EMR) to Reduce Central Line Associated Blood Stream Infections (CLABSI) Rates in the Pediatric Intensive Care Unit by Improving Maintenance Bundle Compliance by Mazloom, Anisha, Steffen, Katherine, Palmquist, Andrew, Godin, Margie, Garnholz, Derek

“…Purpose: Central line associated blood stream infections (CLABSIs) prolong hospitalizations, increase exposure to infectious disease and antibiotics, and…”
Get full text

Ensuring No Death Is Ignored: Development of a Hospital Mortality Review and Notification System by Bates, Katherine E., Freeland, Bethany, Levy, Kathryn L., Lombel, Rebecca M., Mazloom, Anisha, Meerkov, Meera S., Monroe, Kimberly K., Pritz, Benjamin W., Sears, Stacey, Strohacker, Courtney, Studt, Lindsay, Thompson, Kathrynn A., Wilson, Danielle, Vartanian, Rebecca J.

“…BACKGROUND AND OBJECTIVES Standardized review of mortalities may identify potential system improvements. We designed a hospitalwide identification, review, and…”
Get full text

Molecular characteristics of CTA056, a novel interleukin-2-inducible T-cell kinase inhibitor that selectively targets malignant T cells and modulates oncomirs by Guo, Wenchang, Liu, Ruiwu, Ono, Yoko, Ma, Ai-Hong, Martinez, Anthony, Sanchez, Eduardo, Wang, Yan, Huang, Wenzhe, Mazloom, Anisha, Li, Jixian, Ning, Jinying, Maverakis, Emanual, Lam, Kit S, Kung, Hsing-Jien

“…Interleukin-2-inducible T-cell kinase (Itk) is a member of the Btk (Bruton's tyrosine kinase) family of tyrosine kinases. Itk plays an important role in normal…”
Get more information

Discovery and characterization of a high-affinity and high-specificity peptide ligand LXY30 for in vivo targeting of alpha 3 integrin-expressing human tumors by Xiao, Wenwu, Li, Tianhong, Bononi, Fernanda C, Lac, Diana, Kekessie, Ivy A, Liu, Yanlei, Sanchez, Eduardo, Mazloom, Anisha, Ma, Ai-hong, Lin, Jia, Tran, Jimmy, Yang, Kevin, Lam, Kit S, Liu, Ruiwu

“…alpha 3 beta 1 integrin is overexpressed in several types of human cancer and is associated with poor prognosis, metastasis, and resistance to cancer…”
Get full text

Discovery and characterization of a high-affinity and high-specificity peptide ligand LXY30 for in vivo targeting of α3 integrin-expressing human tumors by Xiao, Wenwu, Li, Tianhong, Bononi, Fernanda C., Lac, Diana, Kekessie, Ivy A., Liu, Yanlei, Sanchez, Eduardo, Mazloom, Anisha, Ma, Ai-hong, Lin, Jia, Tran, Jimmy, Yang, Kevin, Lam, Kit S., Liu, Ruiwu

“…Background α3β1 integrin is overexpressed in several types of human cancer and is associated with poor prognosis, metastasis, and resistance to cancer…”
Get full text

Abstract 368: Development of a highly potent and non-invasive optical imaging agent for glioblastoma by Liu, Ruiwu, Xiao, Wenwu, Bononi, Fernanda C., Sanchez, Eduardo, Liu, Yanlei, Mazloom, Anisha, Tseng, Harry, Lam, Kit S.

“…Abstract Using the “one-bead one-compound” (OBOC) combinatorial library approach, we have previously identified a peptide ligand LXY1, cyclic…”
Get full text

Abstract 3580: Discovery and SAR study of a novel and potent Itk inhibitor as a targeted therapeutic agent for T-cell lymphoma and leukemia by Liu, Ruiwu, Guo, Wenchang, Ma, Aihong, Sanchez, Eduardo, Wang, Yan, Li, Jixian, Xu, Chunping, Ning, Jinying, Huang, Wenzhe, Mazloom, Anisha, Song, Aimin, Lam, Kit S., Xia, Michelle, Chen, Yiyou, Kung, Hsing-Jien

“…Abstract Itk (IL2-inducible T-cell kinase) is a non-receptor protein tyrosine kinase. It is selectively expressed in T cells, Mast cells, and NK cells. It…”
Get full text

Discovery and characterization of a high-affinity and high-specificity peptide ligand LXY30 for in vivo targeting of [alpha]3 integrin-expressing human tumors by Xiao, Wenwu, Li, Tianhong, Bononi, Fernanda C, Lac, Diana, Kekessie, Ivy A, Liu, Yanlei, Sanchez, Eduardo, Mazloom, Anisha, Ma, Ai-hong, Lin, Jia, Tran, Jimmy, Yang, Kevin, Lam, Kit S, Liu, Ruiwu

“…Background [alpha]3[beta]1 integrin is overexpressed in several types of human cancer and is associated with poor prognosis, metastasis, and resistance to…”
Get full text